Axcelis Technologies, Inc. (NASDAQ:ACLS) Stock Now Rated “Hold” by Wall Street Analysts

Axcelis Technologies, Inc. (NASDAQ:ACLS) has been given a consensus rating of “Hold” by the five brokerages that are covering the stock, Marketbeat reports. One research analyst has rated the stock with a sell rating, three have issued a hold rating and one has issued a buy rating on the company. The average 1-year target price among analysts that have issued a report on the stock in the last year is $148.67.

A number of research analysts have recently commented on ACLS shares. Weiss Ratings raised Axcelis Technologies from a “hold (c-)” rating to a “hold (c)” rating in a research note on Friday, October 16th. Craig Hallum cut Axcelis Technologies from a “buy” rating to a “hold” rating and set a $140.00 price objective for the company. in a report on Friday, August 7th.

Institutional Trading of Axcelis Technologies

A number of large investors have recently made changes to their positions in the stock. Reinhart Partners LLC. increased its position in shares of Axcelis Technologies by 14.2% during the third quarter. Reinhart Partners LLC. now owns 1,060,636 shares of the semiconductor company’s stock worth $139,134,000 after acquiring an additional 131,976 shares during the period. Dimensional Fund Advisors LP boosted its holdings in shares of Axcelis Technologies by 0.4% in the first quarter. Dimensional Fund Advisors LP now owns 844,097 shares of the semiconductor company’s stock valued at $78,565,000 after purchasing an additional 3,057 shares during the period. The Manufacturers Life Insurance Company boosted its holdings in shares of Axcelis Technologies by 3,402.5% in the first quarter. The Manufacturers Life Insurance Company now owns 491,745 shares of the semiconductor company’s stock valued at $45,772,000 after purchasing an additional 477,705 shares during the period. Bank of New York Mellon Corp bought a new stake in Axcelis Technologies during the 2nd quarter valued at $38,830,000. Finally, Principal Financial Group Inc. raised its position in Axcelis Technologies by 5.1% during the 1st quarter. Principal Financial Group Inc. now owns 210,202 shares of the semiconductor company’s stock valued at $19,566,000 after purchasing an additional 10,177 shares in the last quarter. 89.98% of the stock is owned by hedge funds and other institutional investors.

Axcelis Technologies Stock Up 2.3%

Shares of NASDAQ:ACLS opened at $97.38 on Friday. The company has a current ratio of 4.90, a quick ratio of 3.21 and a debt-to-equity ratio of 0.04. Axcelis Technologies has a 12 month low of $73.60 and a 12 month high of $193.78. The company has a 50-day moving average price of $117.35 and a 200 day moving average price of $122.69. The company has a market cap of $3.01 billion, a price-to-earnings ratio of 32.68, a PEG ratio of 2.91 and a beta of 1.88.

Axcelis Technologies (NASDAQ:ACLS) last issued its quarterly earnings data on Thursday, August 6th. The semiconductor company reported $1.06 earnings per share for the quarter, topping the consensus estimate of $0.89 by $0.17. The company had revenue of $215.18 million for the quarter, compared to analysts’ expectations of $205.03 million. Axcelis Technologies had a return on equity of 11.69% and a net margin of 10.71%. The firm’s revenue for the quarter was up 10.6% on a year-over-year basis. During the same period in the previous year, the firm posted $1.13 earnings per share. Axcelis Technologies has set its Q3 2026 guidance at 1.110-1.110 EPS. As a group, equities research analysts predict that Axcelis Technologies will post 3.39 earnings per share for the current year.

About Axcelis Technologies

Axcelis Technologies, Inc develops and manufactures equipment used in the fabrication of semiconductor devices. The company is best known for its ion implantation systems, which precisely introduce dopant atoms into silicon wafers to control the electrical properties of semiconductor components.

Its product portfolio includes the Purion family of ion implantation systems, designed for applications such as high-current, medium-current and high-energy implantation. Axcelis also provides related aftermarket products and services, including spare parts, equipment upgrades, process support and customer training.

Headquartered in Beverly, Massachusetts, Axcelis serves semiconductor manufacturers and other customers in major chip-production regions worldwide.